These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 30145321

  • 1. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice.
    Podkowa K, Pilc A, Podkowa A, Sałat K, Marciniak M, Pałucha-Poniewiera A.
    Neuropharmacology; 2018 Oct; 141():214-222. PubMed ID: 30145321
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
    Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):1066-74. PubMed ID: 20562216
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of mGlu₇ receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains.
    O'Connor RM, Cryan JF.
    Behav Pharmacol; 2013 Apr 01; 24(2):105-13. PubMed ID: 23455446
    [Abstract] [Full Text] [Related]

  • 9. The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.
    Bradley SR, Uslaner JM, Flick RB, Lee A, Groover KM, Hutson PH.
    Pharmacol Biochem Behav; 2012 Mar 01; 101(1):35-40. PubMed ID: 22138407
    [Abstract] [Full Text] [Related]

  • 10. Impact of the metabotropic glutamate receptor7 (mGlu7) allosteric agonist, AMN082, on fear learning and memory and anxiety-like behavior.
    Kotlinska JH, Lopatynska-Mazurek M, Gawel K, Gabka P, Jenda-Wojtanowska M, Kruk-Slomka M, Marszalek-Grabska M, Danilczuk Z, Kedzierska E, Talarek S, Listos J, Gibula-Tarlowska E.
    Eur J Pharmacol; 2019 Sep 05; 858():172512. PubMed ID: 31260653
    [Abstract] [Full Text] [Related]

  • 11. The effects of metabotropic glutamate receptor 7 allosteric agonist N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway.
    Wang WY, Wang H, Luo Y, Jia LJ, Zhao JN, Zhang HH, Ma ZW, Xue QS, Yu BW.
    Neuroscience; 2012 Mar 15; 205():167-77. PubMed ID: 22244976
    [Abstract] [Full Text] [Related]

  • 12. AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice.
    Jenda M, Gawel K, Marszalek M, Komsta L, Kotlinska JH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar 03; 57():166-75. PubMed ID: 25448778
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia.
    Wierońska JM, Stachowicz K, Acher F, Lech T, Pilc A.
    Psychopharmacology (Berl); 2012 Apr 03; 220(3):481-94. PubMed ID: 21952670
    [Abstract] [Full Text] [Related]

  • 15. Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
    Greco B, Lopez S, van der Putten H, Flor PJ, Amalric M.
    J Pharmacol Exp Ther; 2010 Mar 03; 332(3):1064-71. PubMed ID: 19940105
    [Abstract] [Full Text] [Related]

  • 16. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
    Singh P, Singh TG.
    Indian J Pharmacol; 2015 Mar 03; 47(4):388-93. PubMed ID: 26288470
    [Abstract] [Full Text] [Related]

  • 17. A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action.
    Podkowa K, Rzeźniczek S, Marciniak M, Acher F, Pilc A, Pałucha-Poniewiera A.
    Neuropharmacology; 2015 Oct 03; 97():338-45. PubMed ID: 26074092
    [Abstract] [Full Text] [Related]

  • 18. Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.
    Summa M, Di Prisco S, Grilli M, Usai C, Marchi M, Pittaluga A.
    Neuropharmacology; 2013 Mar 03; 66():215-24. PubMed ID: 22564442
    [Abstract] [Full Text] [Related]

  • 19. Metabotropic glutamate 7 receptor agonist AMN082 inhibits glutamate release in rat cerebral cortex nerve terminal.
    Wang CC, Kuo JR, Huang SK, Wang SJ.
    Eur J Pharmacol; 2018 Mar 15; 823():11-18. PubMed ID: 29378190
    [Abstract] [Full Text] [Related]

  • 20. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
    Hughes ZA, Neal SJ, Smith DL, Sukoff Rizzo SJ, Pulicicchio CM, Lotarski S, Lu S, Dwyer JM, Brennan J, Olsen M, Bender CN, Kouranova E, Andree TH, Harrison JE, Whiteside GT, Springer D, O'Neil SV, Leonard SK, Schechter LE, Dunlop J, Rosenzweig-Lipson S, Ring RH.
    Neuropharmacology; 2013 Mar 15; 66():202-14. PubMed ID: 22551786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.